1
TITLE: Characterization, Structure, and Inhibition of the Human Succinyl-CoA:glutarate-CoA Transferase, a Putative Genetic Modifier of Glutaric Aciduria Type 1
AUTHORS: Ruoxi Wu; Susmita Khamrui; Tetyana Dodatko; João Leandro; Amanda Sabovic; Sara Violante; Justin R Cross; Eric Marsan; Kunal Kumar; Robert J DeVita; Michael B Lazarus; Sander M Houten;
PUBLISHED: 2024, SOURCE: ACS Chemical Biology, VOLUME: 19, ISSUE: 7
INDEXED IN: CrossRef
IN MY: ORCID
2
TITLE: Characterization, structure and inhibition of the human succinyl-CoA:glutarate-CoA transferase, a genetic modifier of glutaric aciduria type 1
AUTHORS: Susmita Khamrui; Tetyana Dodatko; Ruoxi Wu; João Leandro; Amanda Sabovic; Sara Violante; Justin R Cross; Eric Marsan; Kunal Kumar; Robert J DeVita; Michael B Lazarus; Sander M Houten;
PUBLISHED: 2024
INDEXED IN: CrossRef
IN MY: ORCID
4
TITLE: Acyl‐CoA dehydrogenase substrate promiscuity: Challenges and opportunities for development of substrate reduction therapy in disorders of valine and isoleucine metabolism
AUTHORS: Sander M Houten; Tetyana Dodatko; William Dwyer; Sara Violante; Hongjie Chen; Brandon Stauffer; Robert J DeVita; Frédéric M Vaz; Justin R Cross; Chunli Yu; João Leandro;
PUBLISHED: 2023, SOURCE: Journal of Inherited Metabolic Disease, VOLUME: 46, ISSUE: 5
INDEXED IN: CrossRef
IN MY: ORCID
5
TITLE: Recessive pathogenic variants in MCAT cause combined oxidative phosphorylation deficiency
AUTHORS: Bryn D Webb; Sara M Nowinski; Ashley Solmonson; Jaya Ganesh; Richard J Rodenburg; Joao Leandro; Anthony Evans; Hieu S Vu; Thomas P Naidich; Bruce D Gelb; Ralph J DeBerardinis; Jared Rutter; Sander M Houten;
PUBLISHED: 2023, SOURCE: eLife, VOLUME: 12
INDEXED IN: CrossRef: 5
IN MY: ORCID
6
TITLE: Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1
AUTHORS: João Leandro; Susmita Khamrui; Chalada Suebsuwong; Peng-Jen Chen; Cody Secor; Tetyana Dodatko; Chunli Yu; Roberto Sanchez; Robert J DeVita; Sander M Houten; Michael B Lazarus;
PUBLISHED: 2022, SOURCE: Open Biology, VOLUME: 12, ISSUE: 9
INDEXED IN: CrossRef: 6
IN MY: ORCID
7
TITLE: Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1
AUTHORS: João Leandro; Susmita Khamrui; Chalada Suebsuwong; Peng-Jen Chen; Cody Secor; Tetyana Dodatko; Chunli Yu; Roberto Sanchez; Robert J DeVita; Sander M Houten; Michael B Lazarus;
PUBLISHED: 2022
INDEXED IN: CrossRef: 1
IN MY: ORCID
8
TITLE: Acyl-CoA dehydrogenase substrate promiscuity limits the potential for development of substrate reduction therapy in disorders of valine and isoleucine metabolism
AUTHORS: Sander M Houten; Tetyana Dodatko; William Dwyer; Hongjie Chen; Brandon Stauffer; Robert J DeVita; Frédéric M Vaz; Chunli Yu; João Leandro;
PUBLISHED: 2022
INDEXED IN: CrossRef
IN MY: ORCID
9
TITLE: Functional Versatility of the Human 2-Oxoadipate Dehydrogenase in the L-Lysine Degradation Pathway toward Its Non-Cognate Substrate 2-Oxopimelic Acid
AUTHORS: Natalia S Nemeria; Balint Nagy; Roberto Sanchez; Xu Zhang; João Leandro; Attila Ambrus; Sander M Houten; Frank Jordan;
PUBLISHED: 2022, SOURCE: International Journal of Molecular Sciences, VOLUME: 23, ISSUE: 15
INDEXED IN: CrossRef: 4
IN MY: ORCID
10
TITLE: Glutaric aciduria type 3 is a naturally occurring biochemical trait in inbred mice of 129 substrains
AUTHORS: João Leandro; Aaron Bender; Tetyana Dodatko; Carmen Argmann; Chunli Yu; Sander M Houten;
PUBLISHED: 2021, SOURCE: Molecular Genetics and Metabolism, VOLUME: 132, ISSUE: 2
INDEXED IN: Scopus CrossRef: 6
IN MY: ORCID
Page 1 of 5. Total results: 45.